1.Development of group psychotherapy in China: A review from bibliometric perspective
Yingjun ZHANG ; Cuiping TU ; Zhaoran HU ; Wei OU ; Yimei ZHANG ; Xubin ZHANG ; Qingxue ZHANG ; Rahmatulloev KHUSRAVSHO ; Fumin FAN
Chinese Mental Health Journal 2017;31(5):356-363
Objective:To figure out the development status of group psychotherapy and its problems and trends in China.Methods:Properties and contents,intervention programs and methods of 386 chosen articles from key journals of psychology and Doctor & Master Thesis in the group psychotherapy area were examined with bibliometric analyses and content analysis.Result:It showed a fast increase in properties and contents for the last 15 years.The proportion of clinical and sub-clinical study was 1 ∶ 4.Totally 53.9% of studies focused on anxiety and depression,89.4% were quantitative studies and 86.9% were effect studies.As for the intervention programs,36.5% were CBT,90.0% were short-term treatment group below 12 times,35.6% were lack of details in introductions and 67.8% had other missing descriptions of group leader.As for the methods,34.9% of participants were undergraduates,experimental (34.9%) and comprehensive (44.6%) methods were dominant,and difference test (58.3%) was most widely used statistical analysis.The self-report effect evaluation accounted for about 91.4%,and the follow-up studies were less than 22%.Totally 42.9% of studies were lack of ethical consideration.Conclusion:The status of group psychotherapy in China is still in its early developmental phase,which need further standardization and improvement.
2.Regulatory mechanism of p38MAPK signaling pathway on renal tissue inflammation in chronic kidney disease and interventional effect of traditional Chinese medicine.
Qing ZHAO ; Yigang WAN ; Chaojun WANG ; Qingxue WEI ; Haoli CHEN ; Xianjie MENG ; Jian YAO
China Journal of Chinese Materia Medica 2012;37(12):1700-1704
The inflammatory reaction of renal tissues and its relevant tissue damages (such as glomerulosclerosis and renal interstitial fibrosis) are important factors for the development of chronic kidney diseases (CKD) to end-state renal diseases. Of them, p38 mitogen-activated protein kinase (MAPK) signaling pathway plays an important role in regulating expression and bioactivity of multiple nuclear transcription factors, impacting synthesis of downstream inflammatory mediators and activating inflammatory cells. Some monomer traditional Chinese medicines and their extracts (such as emodin and berberine) and some traditional Chinese medicine compound prescriptions (such as Yishen Huoxue decoction) can affect inflammatory reaction of renal tissues by regulating p38MAPK signaling pathway, thas improving reduce glomerulus and renal interstitial inflammatory injury.
Animals
;
Chronic Disease
;
Humans
;
Inflammation
;
drug therapy
;
pathology
;
Kidney Diseases
;
drug therapy
;
pathology
;
Medicine, Chinese Traditional
;
methods
;
Signal Transduction
;
drug effects
;
p38 Mitogen-Activated Protein Kinases
;
metabolism
3.Mechanisms and effects of chinese herbal medicine delaying progression of chronic renal failure.
Qing FENG ; Yigang WAN ; Chunming JIANG ; Chaojun WANG ; Qingxue WEI ; Qing ZHAO ; Jian YAO
China Journal of Chinese Materia Medica 2011;36(9):1122-1128
In this review,firstly,it has been discussed the mechanisms of Chinese herbal medicine ameliorating glomerulosclerosis and renal interstitial fibrosis during the progression of chronic renal failure (CRF) by improving glomerular hemodynamics turbulence, podocyte injury, transforming growth factor (TGF)-beta over-expression, hyperlipidemia, macrophage infiltration, tubular epithelial myofibroblast transdifferentiation, and nephrotoxicity of proteinuria. Secondly,it has been reported the clinical effects of Chinese herbal medicine improving renal function and some clinical complications in the patients with progressive CRF through various treatments including oral administration or coloclysis of Chinese herbal medicine, oral administration combined with coloclysis of Chinese herbal medicine, and colonic dialysis combined with coloclysis of Chinese herbal medicine. Finally,it has been reviewed the beneficial influences of Chinese herbal medicine on metabolic dysequilibrium of calcium and phosphonium, microinflammatory state, and uremic toxins in patients with uremia.
Animals
;
Drugs, Chinese Herbal
;
therapeutic use
;
Humans
;
Kidney
;
drug effects
;
metabolism
;
pathology
;
Kidney Failure, Chronic
;
drug therapy
;
Transforming Growth Factor beta
;
metabolism
4.Mechanisms and effects of Abelmoschus manihot preparations in treating chronic kidney disease.
Ping CHEN ; Yigang WAN ; Chaojun WANG ; Qing ZHAO ; Qingxue WEI ; Yue TU ; Xuejiao YIN
China Journal of Chinese Materia Medica 2012;37(15):2252-2256
Abelmoschus manihot (AM) is a medicinal plant rich in twenty kinds of separated active bio-components including flavones, polysaccharides, trannic acid, and long chain hydrocarbons. Among these, total flavones of A. manihot (TFA) are the major active component. In this review, the mechanisms of Huangkui capsule will be discussed as a preparation of AM to treat chronic kidney disease (CKD) by improving immunological reaction, inflammation, renal fibrosis, and renal tubular epithelial injury. Additionally, it has been reported that Huangkui capsule can ameliorate some clinical symptoms, proteinuria, hematuria, and renal function in patients with common CKD, such as nephrotic syndrome, diabetic nephropathy, Henoch-Schönlein purpura nephritis, IgA nephropathy, and membranous nephropathy.
Abelmoschus
;
chemistry
;
Animals
;
Drugs, Chinese Herbal
;
administration & dosage
;
Humans
;
Kidney
;
drug effects
;
metabolism
;
Renal Insufficiency, Chronic
;
drug therapy
;
metabolism